Eli Lilly
- All
- News
- Videos
-
Weight-Loss Drugs Under EU Scanner Amid Suicide Risk Claims
The European Union's drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co. for more information as it reviews the potential risk of suicidal thoughts associated with a new class of weight-loss medicines.
-
Groundbreaking New Alzheimer's Drug Slows Progression Of The Disease, Finds Study
The medication had a successful clinical trial and is expected to be approved by the Food and Drug Administration this fall.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
German Lab Tests Find Certain Antibody Therapies Lose out Against Omicron
German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant, likely reducing treatment options if the new variant prevails.
-
Sun Pharma To Make Eli Lilly's Covid Medicine In India; Shares Gain
Sun Pharmaceutical shares rose as much as 3.51% to hit an intraday high of Rs 703.40 after it signed an agreement with Eli Lilly to make baricitinib.
-
3 Indian Firms To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients.
-
Cipla To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients.
-
US Drugmaker To Donate 400,000 Covid Treatment Tablets To India
Eli Lilly and Co said on Tuesday it would supply 400,000 tablets of its COVID-19 treatment, to be used with Gilead's remdesivir, to India as the country fights a raging pandemic that has morgues and hospitals overflowing.
-
US Allows Emergency Use Of First COVID-19 Antibody Drug
U.S. regulators on Monday authorized emergency use of the first experimental antibody drug for COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions.
-
US Pharma Firm Lilly Pauses COVID Antibody Treatment Trial Over Safety Concern
US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 over an unspecified safety concern, the company said.
-
Eli Lilly Says Its Antibody Therapy May Reduce Covid Hospitalisations
Eli Lilly and Co.'s experimental antibody treatment for Covid-19 reduced the rate at which symptomatic patients were hospitalized compared to a placebo, according to preliminary study results released by the company and its partner.
-
Lilly's COVID-19 Drug Could Be Ready For Use As Soon As September
Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.
-
Government's Plan To Pull In 324 Companies Including Tesla, Glaxo: Report
The government is planning to offer 324 companies including Tesla Inc. and GlaxoSmithKline Plc incentives to set up factories in India in a bid to capitalize from the trade war between China and the US., according to a document seen by Bloomberg.
-
This US Drugmaker To Cut 3,500 Jobs In Bid To Cut Costs
The company expects most of the cuts to come from a voluntary early-retirement program it is offering in the United States.
-
Lupin Partners Eli Lilly To Market Diabetes Drug 'Eglucent'
Lupin had earlier collaborated with Lilly in July, 2011 to promote and distribute Lilly's Huminsulin range of products in India and Nepal.
-
Weight-Loss Drugs Under EU Scanner Amid Suicide Risk Claims
The European Union's drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co. for more information as it reviews the potential risk of suicidal thoughts associated with a new class of weight-loss medicines.
-
Groundbreaking New Alzheimer's Drug Slows Progression Of The Disease, Finds Study
The medication had a successful clinical trial and is expected to be approved by the Food and Drug Administration this fall.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
German Lab Tests Find Certain Antibody Therapies Lose out Against Omicron
German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant, likely reducing treatment options if the new variant prevails.
-
Sun Pharma To Make Eli Lilly's Covid Medicine In India; Shares Gain
Sun Pharmaceutical shares rose as much as 3.51% to hit an intraday high of Rs 703.40 after it signed an agreement with Eli Lilly to make baricitinib.
-
3 Indian Firms To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients.
-
Cipla To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients.
-
US Drugmaker To Donate 400,000 Covid Treatment Tablets To India
Eli Lilly and Co said on Tuesday it would supply 400,000 tablets of its COVID-19 treatment, to be used with Gilead's remdesivir, to India as the country fights a raging pandemic that has morgues and hospitals overflowing.
-
US Allows Emergency Use Of First COVID-19 Antibody Drug
U.S. regulators on Monday authorized emergency use of the first experimental antibody drug for COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions.
-
US Pharma Firm Lilly Pauses COVID Antibody Treatment Trial Over Safety Concern
US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 over an unspecified safety concern, the company said.
-
Eli Lilly Says Its Antibody Therapy May Reduce Covid Hospitalisations
Eli Lilly and Co.'s experimental antibody treatment for Covid-19 reduced the rate at which symptomatic patients were hospitalized compared to a placebo, according to preliminary study results released by the company and its partner.
-
Lilly's COVID-19 Drug Could Be Ready For Use As Soon As September
Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.
-
Government's Plan To Pull In 324 Companies Including Tesla, Glaxo: Report
The government is planning to offer 324 companies including Tesla Inc. and GlaxoSmithKline Plc incentives to set up factories in India in a bid to capitalize from the trade war between China and the US., according to a document seen by Bloomberg.
-
This US Drugmaker To Cut 3,500 Jobs In Bid To Cut Costs
The company expects most of the cuts to come from a voluntary early-retirement program it is offering in the United States.
-
Lupin Partners Eli Lilly To Market Diabetes Drug 'Eglucent'
Lupin had earlier collaborated with Lilly in July, 2011 to promote and distribute Lilly's Huminsulin range of products in India and Nepal.
